Cytokine-cytokine receptor interaction
|
KEGG Pathway
|
229
|
−0.200253028
|
0.288086617
|
3.06E-06
|
5.69E-04
|
Down
|
Metabolism of xenobiotics by cytochrome P450
|
KEGG Pathway
|
61
|
−0.287221818
|
0.167801921
|
1.58E-04
|
0.014739788
|
Down
|
Vitamin A (retinol) metabolism
|
EHMN Pathway Gene
|
25
|
−0.428286702
|
0.069834019
|
3.14E-04
|
0.015401391
|
Down
|
N-Glycan biosynthesis
|
KEGG Pathway
|
44
|
0.359631955
|
9.346216996
|
0.001289861
|
0.079971357
|
Up
|
Proteogylcan biosynthesis
|
EHMN Pathway Gene
|
21
|
−0.40681778
|
0.079801493
|
0.001359963
|
0.0333191
|
Down
|
Oxidative phosphorylation
|
KEGG Pathway
|
101
|
0.206370232
|
3.605679051
|
0.004079267
|
0.176257686
|
Up
|
C21-Steroid hormone metabolism
|
KEGG Pathway
|
12
|
−0.42731737
|
0.07025597
|
0.00473811
|
0.176257686
|
Down
|
Proteasome
|
KEGG Pathway
|
21
|
0.442939628
|
15.68486443
|
0.006686061
|
0.18372292
|
Up
|
Ribosome
|
KEGG Pathway
|
59
|
0.255415299
|
4.890555948
|
0.006914303
|
0.18372292
|
Up
|
Natural killer cell mediated cytotoxicity
|
KEGG Pathway
|
116
|
−0.157029295
|
0.376862256
|
0.008222671
|
0.188057588
|
Down
|
Dichotomous model - GO (FDR <0.01, P-value <5e-4, Odds ratio >5)
|
Name
|
Concept type
|
#Genes
|
Coeff
|
Odds ratio
|
P-value
|
FDR
|
Enriched
|
Epidermis development
|
GO Biological Process
|
120
|
−0.288785876
|
0.166178787
|
7.22E-08
|
2.83E-05
|
Down
|
Ectoderm development
|
GO Biological Process
|
130
|
−0.27220051
|
0.184220938
|
1.69E-07
|
4.41E-05
|
Down
|
Sensory perception of chemical stimulus
|
GO Biological Process
|
81
|
−0.326598184
|
0.131377584
|
2.59E-07
|
5.80E-05
|
Down
|
Digestion
|
GO Biological Process
|
85
|
−0.314243619
|
0.141861941
|
4.72E-07
|
8.22E-05
|
Down
|
Ribonucleoprotein complex biogenesis and assembly
|
GO Biological Process
|
161
|
0.282212002
|
5.776725456
|
5.25E-07
|
8.23E-05
|
Up
|
Regulation of homeostatic process
|
GO Biological Process
|
18
|
−0.534094322
|
0.03618224
|
2.19E-06
|
3.12E-04
|
Down
|
G-protein-couples receptor binding
|
GO Molecular Function
|
69
|
−0.298251857
|
0.156684914
|
1.91E-05
|
0.001995771
|
Down
|
Chemokine binding
|
GO Molecular Function
|
26
|
−0.431856927
|
0.068301636
|
2.48E-05
|
0.002021324
|
Down
|
Sensory perception of smell
|
GO Biological Process
|
56
|
−0.318324204
|
0.138309662
|
2.90E-05
|
0.002387889
|
Down
|
Serine-type endopeptidase inhibitor activity
|
GO Molecular Function
|
73
|
−0.285841884
|
0.169247136
|
2.90E-05
|
0.002021324
|
Down
|
Continuous model - pathway (FDR <0.2, P-value <0.02)
|
Name
|
Concept type
|
#Genes
|
Coeff
|
Odds ratio
|
P-Value
|
FDR
|
Enriched
|
Cytokine-cytokine receptor interation
|
KEGG Pathway
|
229
|
−0.205604496
|
0.278663207
|
9.68E-09
|
1.80E-06
|
Down
|
Metabolism of xenobiotics by cytochrome P450
|
KEGG Pathway
|
61
|
−0.2927432
|
0.162141761
|
4.33E-06
|
4.03E-04
|
Down
|
Complement and coagulation cascades
|
KEGG Pathway
|
66
|
0.25256689
|
0.208127535
|
5.11E-05
|
0.003167145
|
Down
|
Plaminogen activating cascade
|
Panther Pathway
|
13
|
−0.497645229
|
0.045380623
|
6.32E-05
|
0.114613557
|
Down
|
Cytokines and Inflammatory Response
|
Biocarta Pathway
|
29
|
−0.33471697
|
0.124913374
|
195E-04
|
0.035217055
|
Down
|
Ribosome
|
KEGG Pathway
|
59
|
0.287062223
|
5.953499593
|
2.21E-04
|
0.010264183
|
Up
|
Vitamin A (retinol) metabolism
|
EHMN Pathway Gene
|
25
|
−0.385600917
|
0.091048898
|
2.51E-04
|
0.012317017
|
Down
|
Autoimmune thyroid disease
|
KEGG Pathway
|
47
|
−0.26174305
|
0.196590877
|
3.38E-04
|
0.012575822
|
Down
|
Oxidative phosphorylation
|
KEGG Pathway
|
101
|
0.209255664
|
3.670918657
|
4.30E-04
|
0.013316379
|
Up
|
Asthma
|
KEGG Pathway
|
26
|
−0.321259111
|
0.135809858
|
6.79E-04
|
0.015209508
|
Down
|
Continuous model - GO (FDR <0.01, P-value <5e-4, Odds ratio >5)
|
Name
|
Concept type
|
#Genes
|
Coeff
|
Odds ratio
|
P-Value
|
FDR
|
Enriched
|
Sensory perception of chemical stimulus
|
GO Biological Process
|
81
|
−0.378994195
|
0.094865006
|
8.35E-14
|
6.54E-11
|
Down
|
Digestion
|
GO Biological Process
|
85
|
−0.332578826
|
0.126584265
|
6.03E-11
|
2.10E-08
|
Down
|
Epidermis development
|
GO Biological Process
|
120
|
−0.281910372
|
0.17343325
|
2.06E-10
|
5.38E-08
|
Down
|
Ectoderm development
|
GO Biological Process
|
130
|
−0.26538019
|
0.192197099
|
7.20E-10
|
1.34E-07
|
Down
|
Sensory perception of smell
|
GO Biological Process
|
56
|
−0.372825845
|
0.09857215
|
7.72E-10
|
1.34E-07
|
Down
|
Acute inflammatory response
|
GO Biological Process
|
69
|
−0.321398071
|
0.135692626
|
1.28E-08
|
1.55E-06
|
Down
|
Serine-type endopeptidase inhibitor activity
|
GO Molecular Function
|
73
|
−0.304550109
|
0.150670556
|
3.09E-08
|
2.71E-06
|
Down
|
olfactory receptor activity
|
GO Molecular Function
|
42
|
−0.377710874
|
0.095624611
|
3.89E-08
|
2.71E-06
|
Down
|
Immunoglobulin mediated immune response
|
GO Biological Process
|
50
|
−0.352071918
|
0.11214204
|
5.47E-08
|
5.72E-06
|
Down
|
B cell mediated immunity
|
GO Biological Process
|
51
|
−0.34665743
|
0.115979703
|
7.23E-08
|
7.08E-06
|
Down
|
Continuous model - metabolite
|
Progesterone
|
Metabolite
|
34
|
−0.456431331
|
0.058628061
|
2.25E-07
|
1.04E-04
|
Down
|
Testerone
|
Metabolite
|
53
|
−0.364806957
|
0.103608877
|
5.41E-07
|
1.25E-04
|
Down
|
Trichloroethanol
|
Metabolite
|
46
|
−0.365998732
|
0.102844341
|
2.20E-06
|
2.59E-04
|
Down
|
Estradiol-17beta
|
Metabolite
|
47
|
−0.362340859
|
0.105208999
|
2.25E-06
|
2.59E-04
|
Down
|